Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]
News [11324]
Articles [47]
Editorials [10]
Conferences [196]
elearning [4]
'Survivor passport' for survivors of childhood leukaemia
Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel...
'Survivor passport' for survivors of childhood leukaemia ( Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel, Germany )
1 Oct 2015
Progression of childhood cancers in Europe
Prof Gilles Vassal - University Paris-Sud, Orsay, France
Progression of childhood cancers in Europe ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )
1 Oct 2015
Expanding access to crizotinib using a biomarker-driven approach
Prof Gilles Vassal - University Paris-Sud, Orsay, France
Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )
1 Oct 2015
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise
Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC
Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2015
Latest in lung cancer from ECC 2015
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
28 Sep 2015
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...
Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015
Economics of radiotherapy and radiotherapy boost for high grade invasive breast...
Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands
Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer ( Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands )
28 Sep 2015
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors...
Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland
EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control ( Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland )
27 Sep 2015
Melanoma immunotherapy latest and TVEC plus pembrolizumab
Dr Georgina Long - University of Sydney, Sydney, Australia
Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )
27 Sep 2015
Tailoring treatment strategies in prostate cancer: expert insight
Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu
Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )
26 Sep 2015
Large variations found in survival from blood cancers between European countries
Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
Large variations found in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation